Enzymatic treatments are often dismissed as being prohibitively expensive for price-sensitive applications. This argument is becoming progressively less valid as the enzyme-producing industry matures, and enzyme prices drop. The enzyme used this research is marketed primarily as an additive for poultry rations. The practicality of a protease-MBM treatment process depends largely on whether it can be designed to work rapidly with a relatively small amount of enzyme. This research shows that additional unit operations such as milling, solvent extraction, and hydration improve the performance of the enzyme in such a process by allowing the enzyme to rapidly penetrate and hydrolyze throughout the particle, rather than just acting on the particle��s surface. Further improvements might be achieved by adopting the pressure or vacuum treatments that have been used to force enzyme solution into plant tissue, but this depends largely on the existence of gas-filled spaces within the particles. The eye receives information from the outside as the Acetrizoic acid retinal image, converting it into electrical signals for the brain, leading to visual perception. The retinal image is Schisandrol-B stabilized by the balance of intraocular pressure and the curvatures of the scleral and corneal envelope. In order to keep this balance, the rigidity of the sclera and the cornea are essential, especially the sclera must be rigid enough for the eyeball to be rotated by powerful extraocular muscles adhering to the sclera. The sclera and the corneal stroma that are anatomically continuous have common characteristics such as mechanical rigidity, and share a common origin, i.e., the neural crest. However, the cornea and the sclera are different in transparency: the cornea is completely transparent to produce a sharp image on the retina; the sclera is opaque to avoid the internal light scattering affecting the retinal image.Multipotent progenitor/precursor cells of corneal stroma are identified from the mouse eye. On the other hand, existence of multipotent progenitor/precursor cells in the sclera remains unclarified.